47. Buerger disease Clinical trials / Disease details
Clinical trials : 9 / Drugs : 13 - (DrugBank : 7) / Drug target genes : 6 - Drug target pathways : 15
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | JPRN-UMIN000005227 | 2011/03/01 | 09/03/2011 | Transplantation of autologous and G-CSF mobilized mononuclear cells in patients with critical limb ischemia (CLI) | CLI (Atherosclerotic PAD/Buerger disease ) | Subcutaneous administration of G-CSF, Harvest and implantation of PB-MNC | Regenerative Medicine Unit, Division of Vascular Regeneration Therapy, Institute of Biomedical Research and Innovation (IBRI) | NULL | Complete: follow-up complete | 20years-old | 80years-old | Male and Female | 5 | Not selected | Japan |